LEGN logo

Legend Biotech Corp. (LEGN)$29.37

Market Cap: 6.13 BCurrency: USD

Research Snapshot

Static fundamentals, valuation context, and investor signals for Legend Biotech Corp. (LEGN).

HEALTHCARE
BIOTECHNOLOGY

Valuation

N/A

EV/FCF, N/A FCF yield

Quality

N/A

ROIC, N/A FCF margin

Growth

N/A

5Y sales (revenue) CAGR

Balance sheet

N/A

Debt/equity, N/A current ratio

Superinvestors

1

Top: Meridian Contrarian Fund (1.4%)

Strengths to research

No strong positive screening signals were detected from the checked-in dataset.

Watchouts

  • Full metrics are not available yet for this ticker.
Annual data: 0 periods
Quarterly data: 5 periods
Stock snapshot: May 24, 2026
Static dataset: May 25, 2026

Quality Scorecard

Build-time composite score for LEGN.

Grade F
0
/ 100

Peer Comparison

Target stock against 8 market-cap comparable peers.

Heat map: red worst to green best
LEGN
Target
Legend Biotech Corp.$6.1BN/AN/AN/AN/AN/AN/AN/AN/A
AXSMAxsome Therapeutics Inc.$5.7B-64.1x-57.1x-207.5%N/A-14.7%N/AN/AN/A
IONSIonis Pharmaceuticals Inc.$5.4B-31.7x-21.2x-16.6%5.3%-33.9%N/AN/AN/A
BBIOBridgeBio Pharma Inc.$7.3B-18.3x-19.5xN/A127.4%-89.0%N/AN/AN/A
HALOHalozyme Therapeutics$7.5B26.7x14.7x14.5%39.2%46.2%N/A4.2xN/A
TECHBio-Techne Corp.$7.9B104.8x30.1x3.8%10.5%21.0%64.8%-0.8xN/A
ROIVRoivant Sciences Ltd$8.3B-55.5x-9.0x-6.6%-19.1%-9183.5%N/AN/AN/A
PCVXVaxcyte Inc.$4.4B-8.4x-6.3x-0.0%N/AN/AN/AN/AN/A
MRNAModerna, Inc.$10.8B-6.5x-4.0x-32.6%19.3%-106.2%N/AN/AN/A

Financial Charts

No financial data available for LEGN (annual).

1 superinvestors own LEGN

Current quarter ownership and quarter-over-quarter share changes.

Superinvestor ownership
FundSharesValue% PortfolioQoQ Change
Meridian Contrarian Fund

Meridian Contrarian Fund

233,821$8M1.45%▲ +16.4%